4//SEC Filing
Guyer Charles Greg 4
Accession 0001048477-25-000031
CIK 0001048477other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:22 PM ET
Size
8.2 KB
Accession
0001048477-25-000031
Insider Transaction Report
Form 4
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2025-03-17+30,880→ 30,880 totalExercise: $71.55From: 2026-03-17Exp: 2035-03-16→ Common Stock (30,880 underlying) - Award
Common Stock
2025-03-17+13,310→ 80,838 total - Tax Payment
Common Stock
2025-03-14$69.44/sh−20,127$1,397,619→ 67,528 total
Footnotes (2)
- [F1]Restricted stock units granted March 17, 2025. Price not applicable.
- [F2]Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001811096
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 6:22 PM ET
- Size
- 8.2 KB